Boyle Scott N bought CCCC
February 14, 2024 · Form 4 insider transaction
Boyle Scott N bought 27,300 shares of C4 Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
27,300
Price
$0.00
Total value
N/A
InsiderBoyle Scott N
Role—
CompanyC4 Therapeutics, Inc. (CCCC)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 14, 2024
Filing dateFebruary 15, 2024
Shares owned after52,330
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents RSUs. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2025.